IQVIA

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences industry. Formed from the merger of IMS Health and Quintiles, the company integrates vast amounts of proprietary healthcare data, cutting-edge analytics, and deep scientific expertise to help clients drive healthcare innovation and improve patient outcomes. It operates at the intersection of data, science, and technology to support the entire lifecycle of medical products. The company serves as one of the world's largest Contract Research Organizations (CROs), managing and executing clinical trials for pharmaceutical, biotechnology, and medical device companies from early-stage development through post-market surveillance. Beyond clinical development, IQVIA provides technology platforms, real-world evidence solutions, and consulting services focused on commercial effectiveness, market access, and optimizing research and development processes. Their solutions enable clients to make better strategic decisions, accelerate drug development, and enhance commercialization efforts. IQVIA's global presence extends across more than 100 countries, including operations in Argentina, supporting pharmaceutical companies, biotech firms, medical device manufacturers, healthcare payers, providers, and governmental organizations in their efforts to advance global health.

Last researched: 3/29/2026

0 of 65 listings flagged by automated signals